FDA Backs Cholesterol Drug Vytorin

Related Encyclopedia • Abdominoplasty • Acidophilus • Alzheimer's Disease • Aneurysms More... Related Healthscout Videos Custom Ankle Replacements Shutting Down Tremor. Disaster Heart Attacks Teaching Old Docs New Tricks More... Related Animations • Alzheimer's Disease Video Animation • Angioplasty • Coronary Bypass Surgery • Erectile Dysfunction More... Related Drug Information • Accupril • Actonel • Altace • Avapro More... Related News Articles • Drugs Provide Same Benefit as Angioplasty for Diabetics, at Lower Cost • Study: Migraine Raises Risk of Stroke • Vitamin D Deficiency Linked to Cardiovascular Disease • Low Vitamin D Tied to Estrogen Decline More...

Page:  << Prev | 1 | 2

Vytorin was back in the news last September when a study found no definitive link between the drug and cancer risk.

The results of an earlier, small study published last year suggested that Vytorin might boost the chances of developing cancer. In that earlier study, called SEAS, researchers found that among patients taking Vytorin, 101 developed cancer, compared with 65 in the control group. Among these patients, 39 taking Vytorin died, compared with 23 in the control group.

But, a three-study analysis in the Sept. 2, 2008, issue of the New England Journal of Medicine did not find compelling evidence of such a connection.

Text Continues Below

---

Merck/Schering-Plough Pharmaceuticals, the makers of Zetia and Vytorin, had been criticized last year for not releasing the Enhance test results earlier.

More information

For more information on lowering cholesterol, visit the American Heart Association.

Page:  << Prev | 1 | 2